HomeCDTTW • NASDAQ
add
Conduit Pharmaceuticals Inc
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.14M | 138.78% |
Net income | -5.38M | -155.60% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 433.00K | — |
Total assets | 3.30M | 66,000.00% |
Total liabilities | 8.77M | -43.12% |
Total equity | -5.46M | — |
Shares outstanding | 96.00M | — |
Price to book | -0.17 | — |
Return on assets | -190.95% | — |
Return on capital | 261.75% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -5.38M | -155.60% |
Cash from operations | -1.51M | -253.50% |
Cash from investing | -224.00K | -155.45% |
Cash from financing | 113.00K | 927.27% |
Net change in cash | -1.62M | -20,212.50% |
Free cash flow | -1.03M | — |
About
Founded
2019
Website
Employees
7
